Ann: Trading Halt, page-228

First 228 Last

Share
Profile

Follow
zx65

1,573 Posts.

190

09/12/19

22:30

Post #: 41879230
Share

Originally posted by Vivo ↑

Lol. Yes, I'm just as guilty but I know when I have been an idiot. I think the company have done alright if this capital raise is successful. I assume the company looked at the trajectory of the upcoming results and concluded that they would be better going early with a pump on the CF33 "cure for all forms of cancer". They've got to do what they have got to do. They don't have control over the results and they've got to keep this thing going. Also, the upcoming results may actually be quite good, but we have seen many times the share price go down on biotechs after moderately good results.

My reading of the tea leaves is they are just setting up to cover all bases going forward, there will be a share consolidation next (imo). It puts them in a better position to negotiate on good results and to weather the storm of bad results. If all else fails they will have the resources to get to the next wave as CF33 results start coming in.

Expand

CF33 is now a major IMU focus. Why?

Rhetorical q as its highly saleable to the overall market and changes focus on hervaxx.....why?

Will have to answer that q with another q. Why is a new carrot being dangled at the market?

Please ponder the above as it is worthwhile imo.

Then investigate historic events of say each new carrot that has ben dangled at the market by IMU. Perhaps therein may be the answer to all the above imo.

IMU Price at posting: 3.4¢ Sentiment: Buy Disclosure: Held
3 Upvote

1 Great analysis

Reply